REGENERON PHARMACEUTICALS
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for REGENERON PHARMACEUTICALS NOTE 1.875%10/0, CUSIP 75886FAD9.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for REGENERON PHARMACEUTICALS NOTE 1.875%10/0, CUSIP 75886FAD9.